JPH10505841A - 喫煙を制御する組成物および方法 - Google Patents
喫煙を制御する組成物および方法Info
- Publication number
- JPH10505841A JPH10505841A JP8510468A JP51046896A JPH10505841A JP H10505841 A JPH10505841 A JP H10505841A JP 8510468 A JP8510468 A JP 8510468A JP 51046896 A JP51046896 A JP 51046896A JP H10505841 A JPH10505841 A JP H10505841A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- smoke
- smoking
- controlling
- desire
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Addiction (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Psychiatry (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.喫煙を制御する組成物、該組成物は以下のものよりなる: (a)キサンチンオキシダーゼ阻害剤; (b)チトクローム誘導化合物; (c)糖; (d)リン酸源;随意に、 (e)1またはそれ以上の薬理学的に許容しうる担体、若しくは賦形剤。 2.該キサンチンオキシダーゼ阻害剤が、フラボノイド、プリン類縁体、キナゾ リン、トリアジン、及びピラザロ(3、4ーd)ピリミジンから選択される請求 項1記載の組成物。 3.該フラボノイドがフラボノン類、フラボノール類、フラボン類、アントシア ニン類、カテコール類、及びカテコールタンニン類の群から選択される請求項2 記載の組成物。 4.該フラボノイドが植物起源からの抽出物の形である請求項2または3記載の 組成物。 5.該フラボノイドがヒヨドリバナからの抽出物である請求項5記載の組成物。 6.化合物オイパリンを含有する請求項5記載の組成物。 7.該キサンチンオキシダーゼ阻害剤がオイパリンである請求項1記載の組成物 。 8.該チトクロームP450誘導物質が多環芳香族炭化水素、塩素化化合物、炭 火焼き肉、または煙精油である請求項1記載の組成物。 9.該チトクローム誘導剤が煙り精油である請求項9記載の組成物。 10.該糖成分が果糖、蔗糖、またはひとにおいて尿酸産生を促進する糖である 請求項1記載の組成物。 11.該リン酸が無機リン酸、有機リン酸、または他のリン含有化合物である請 求項1記載の組成物。 12.該リン酸の起源がリン酸、またはリン酸塩である請求項11記載の組成物 。 13.付加的にビタミンDを含む請求項1記載の組成物。 14.そのような治療が必要な対象者に以下のものよりなる組成物を投与するこ とからなる喫煙願望を制御する方法: (a)キサンチンオキシダーゼ阻害剤; (b)チトクローム誘導化合物 (c)糖 (d)リン酸源;随意に、 (e)1またはそれ以上の薬理学的に許容しうる担体、若しくは賦形剤。 15.該キサンチンオキシダーゼ阻害剤が、フラボノイド、プリン類縁体、キナ ゾリン、トリアジン、及びピラザロ(3、4ーd)ピリミジンから選択される請 求項14記載の喫煙願望を制御する方法。 16.該フラボノイドがフラボノン類、フラボノール類、フラボン類、アントシ アニン類、カテコール類、及びカテコールタンニン類の群から選択される請求項 15記載の喫煙願望を制御する方法。 18.該フラボノイドが植物起源からの抽出物の形である請求項15または16 記載の喫煙願望を制御する方法。 19.該フラボノイドがヒヨドリバナからの抽出物である請求項18記載の喫煙 願望を制御する方法。 20.化合物オイパリンを含有する請求項19記載の喫煙願望を制御する方法。 21.該キサンチンオキシダーゼ阻害剤がオイパリンである請求項14記載の喫 煙願望を制御する方法。 22.該チトクロームP450誘導物質が多環芳香族炭化水素、塩素化化合物、 炭火焼き肉、または煙精油である請求項14記載の喫煙願望を制御する方法。 23.該チトクロームP450誘導物質が煙精油である請求項21記載 の喫煙願望を制御する方法。 24.該糖成分が果糖、蔗糖、またはひとにおいて尿酸産生を促進する糖である 請求項14記載の喫煙願望を制御する方法。 25.該リン酸が無機リン酸、有機リン酸、または他のリン含有化合物である請 求項14記載の喫煙願望を制御する方法。 26.該リン酸起源がリン酸またはリン酸塩である請求項25記載の喫煙願望を 制御する方法。 27.付加的にビタミンDを含む請求項14記載の喫煙願望を制御する方法。 28.喫煙の制御のための以下のものよりなる組成物の使用: (a)キサンチンオキシダーゼ阻害剤; (b)チトクローム誘導化合物 (c)糖 (d)リン酸源;随意に、 (e)1またはそれ以上の薬理学的に許容しうる担体、若しくは賦形剤。 29.喫煙の治療/制御のための薬剤の製造のための請求項28記載の組成物の 使用。 30.薬剤が以下のものからなる喫煙の制御のための薬剤: (a)キサンチンオキシダーゼ阻害剤; (b)チトクローム誘導化合物 (c)糖 (d)リン酸源;随意に、 (e)1またはそれ以上の薬理学的に許容される担体若しくは賦形剤。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPM8353A AUPM835394A0 (en) | 1994-09-23 | 1994-09-23 | Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need |
AU8353 | 1994-09-23 | ||
PCT/AU1995/000621 WO1996009042A1 (en) | 1994-09-23 | 1995-09-21 | Compositions and methods for the control of smoking |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH10505841A true JPH10505841A (ja) | 1998-06-09 |
JP3989538B2 JP3989538B2 (ja) | 2007-10-10 |
Family
ID=3782872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51046896A Expired - Lifetime JP3989538B2 (ja) | 1994-09-23 | 1995-09-21 | 喫煙を制御する組成物および方法 |
Country Status (10)
Country | Link |
---|---|
US (3) | US5883137A (ja) |
EP (1) | EP0777473A4 (ja) |
JP (1) | JP3989538B2 (ja) |
CN (1) | CN1117562C (ja) |
AU (3) | AUPM835394A0 (ja) |
BR (1) | BR9509122A (ja) |
CA (1) | CA2200755A1 (ja) |
MX (1) | MX9702163A (ja) |
NZ (1) | NZ293203A (ja) |
WO (1) | WO1996009042A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001114694A (ja) * | 1999-10-19 | 2001-04-24 | Maruzen Pharmaceut Co Ltd | う蝕防止剤、口腔用剤および飲食物 |
WO2003074049A1 (fr) * | 2002-03-07 | 2003-09-12 | Japan Science And Technology Agency | Agents antitumoraux |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPM835394A0 (en) * | 1994-09-23 | 1994-10-13 | King, Michael G. Dr. | Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need |
US5965625A (en) * | 1997-03-21 | 1999-10-12 | King; Michael Glenn | Compositions and methods for the control of smoking |
AUPO897997A0 (en) * | 1997-09-04 | 1997-09-25 | King, Michael Glenn | Improved compositions and methods for the control of smoking |
FR2771639B1 (fr) * | 1997-12-03 | 2000-05-05 | Sod Conseils Rech Applic | Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a faciliter le sevrage d'individus dependants de la consommation d'une substance engendrant une dependance et/ou une addiction |
EP1055408A1 (de) * | 1999-05-26 | 2000-11-29 | Nutrinova Nutrition Specialties & Food Ingredients GmbH | Sorbatkonservierte Mittel, Verfahren zu deren Herstellung und ihre Verwendung |
US20050037073A1 (en) * | 2000-01-13 | 2005-02-17 | Alpharx Inc. | Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof |
US6789546B2 (en) * | 2001-06-26 | 2004-09-14 | Technion Research & Development Foundation Ltd. | Filters for preventing or reducing tobacco smoke-associated injury in the aerodigestive tract of a subject |
AU2002365070A1 (en) * | 2001-08-03 | 2003-06-30 | Diversa Corporation | P450 enzymes, nucleic acids encoding them and methods of making and using them |
CA2607953A1 (en) * | 2005-05-09 | 2006-11-16 | Tap Pharmaceutical Products, Inc. | Methods for treating nephrolithiasis |
US20070134169A1 (en) * | 2005-12-11 | 2007-06-14 | Rabinoff Michael D | Methods for smoking cessation or alcohol cessation or other addiction cessation |
US20090124623A1 (en) * | 2006-11-13 | 2009-05-14 | Christopher Lademacher | Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors |
EP2101761A4 (en) * | 2006-11-13 | 2010-01-27 | Takeda Pharmaceuticals North A | METHODS FOR PRESERVING RENAL FUNCTION USING XANTHINE OXYDOREDUCTASE INHIBITORS |
KR20090127870A (ko) * | 2007-01-19 | 2009-12-14 | 다케다 파마슈티칼스 노쓰 어메리카, 인코포레이티드 | 크산틴 산화환원효소 저해제들 및 항염증제들을 사용하여 통풍 발열을 방지하거나 또는 통풍 발열의 회수를 감소시키는 방법 |
US20100311756A1 (en) * | 2009-01-22 | 2010-12-09 | Takeda Pharmaceuticals North America, Inc. | Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof |
EP2515918B1 (en) * | 2009-12-21 | 2014-10-08 | RCP Development, Inc. | Smoking cessation lozenge containing tobacco alkaloid and silver salt |
CN103298466B (zh) | 2010-09-10 | 2015-11-25 | 武田制药美国有限公司 | 茶碱和非布索坦的联合治疗方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0028660B1 (de) | 1979-11-10 | 1985-10-23 | Siegfried Aktiengesellschaft | Xanthinoxydasehemmer und Verwendung von Benztriazinderivaten |
JPS63203624A (ja) * | 1987-02-18 | 1988-08-23 | Katsumi Mizumaki | 喫煙を止めるための薬剤 |
JPS6440432A (en) * | 1987-08-04 | 1989-02-10 | Tadao Inagaki | Solution making people come to dislike smoking |
US4997671A (en) * | 1988-09-09 | 1991-03-05 | Nabisco Brands, Inc. | Chewy dog snacks |
JPH03161463A (ja) | 1989-11-20 | 1991-07-11 | Gunze Ltd | キサンチンオキシダーゼ阻害剤 |
JP2924099B2 (ja) * | 1990-06-13 | 1999-07-26 | 茂 川瀬 | 経口節煙剤 |
GB9200047D0 (en) * | 1992-01-03 | 1992-02-26 | Univ Alberta | Nicotine-containing nasal spray |
US5612357A (en) * | 1992-05-18 | 1997-03-18 | Pharmaco Behavioral Associates, Inc. | Use of cotinine to assist in the cessation of tobacco smoking |
US5362496A (en) * | 1993-08-04 | 1994-11-08 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
AU7438894A (en) * | 1993-10-05 | 1995-04-27 | Michael Glenn King | Method for the treatment of diseases caused by compromised xanthine metabolism and methods for detecting said diseases |
US5614501A (en) * | 1994-07-21 | 1997-03-25 | The University Of Montana | Compositions and methods for animal husbandry and for treating gastrointestinal disorders |
AUPM835394A0 (en) | 1994-09-23 | 1994-10-13 | King, Michael G. Dr. | Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need |
US5965625A (en) | 1997-03-21 | 1999-10-12 | King; Michael Glenn | Compositions and methods for the control of smoking |
-
1994
- 1994-09-23 AU AUPM8353A patent/AUPM835394A0/en not_active Abandoned
-
1995
- 1995-09-21 BR BR9509122A patent/BR9509122A/pt not_active Application Discontinuation
- 1995-09-21 CA CA002200755A patent/CA2200755A1/en not_active Abandoned
- 1995-09-21 WO PCT/AU1995/000621 patent/WO1996009042A1/en not_active Application Discontinuation
- 1995-09-21 AU AU35587/95A patent/AU713613B2/en not_active Expired
- 1995-09-21 US US08/809,400 patent/US5883137A/en not_active Expired - Lifetime
- 1995-09-21 CN CN95195822A patent/CN1117562C/zh not_active Expired - Fee Related
- 1995-09-21 JP JP51046896A patent/JP3989538B2/ja not_active Expired - Lifetime
- 1995-09-21 NZ NZ293203A patent/NZ293203A/en not_active IP Right Cessation
- 1995-09-21 EP EP95932578A patent/EP0777473A4/en not_active Withdrawn
- 1995-09-21 AU AU32812/95A patent/AU671577B3/en not_active Ceased
- 1995-09-21 MX MX9702163A patent/MX9702163A/es unknown
-
1998
- 1998-06-11 US US09/095,954 patent/US6288087B1/en not_active Expired - Lifetime
-
2001
- 2001-01-05 US US09/755,460 patent/US6749870B2/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001114694A (ja) * | 1999-10-19 | 2001-04-24 | Maruzen Pharmaceut Co Ltd | う蝕防止剤、口腔用剤および飲食物 |
JP4585066B2 (ja) * | 1999-10-19 | 2010-11-24 | 丸善製薬株式会社 | う蝕防止剤、口腔用剤および飲食物 |
WO2003074049A1 (fr) * | 2002-03-07 | 2003-09-12 | Japan Science And Technology Agency | Agents antitumoraux |
Also Published As
Publication number | Publication date |
---|---|
AUPM835394A0 (en) | 1994-10-13 |
EP0777473A1 (en) | 1997-06-11 |
CN1161647A (zh) | 1997-10-08 |
AU713613B2 (en) | 1999-12-09 |
EP0777473A4 (en) | 2002-08-21 |
CA2200755A1 (en) | 1996-03-28 |
MX9702163A (es) | 1997-06-28 |
US20020028775A1 (en) | 2002-03-07 |
BR9509122A (pt) | 1997-09-02 |
US5883137A (en) | 1999-03-16 |
US6749870B2 (en) | 2004-06-15 |
CN1117562C (zh) | 2003-08-13 |
US6288087B1 (en) | 2001-09-11 |
AU671577B3 (en) | 1996-08-29 |
AU3558795A (en) | 1996-04-09 |
WO1996009042A1 (en) | 1996-03-28 |
JP3989538B2 (ja) | 2007-10-10 |
NZ293203A (en) | 1998-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3989538B2 (ja) | 喫煙を制御する組成物および方法 | |
JP2001511117A (ja) | アルツハイマー痴呆および認識機能低下を治療および予防するためのイソフラボノイド | |
US6465436B2 (en) | Method for treating alcohol intoxication and alcohol abuse | |
US6548510B1 (en) | Pharmaceutical composition containing deoxypeganine for the treatment of nicotine dependence | |
EP2934561B1 (en) | Composition comprising raphanus, theobroma and passiflora for treating opioid and alcohol abuse | |
JP3334725B2 (ja) | 体内アルコール、その代謝物の低下促進剤及び口中清涼剤 | |
US5965625A (en) | Compositions and methods for the control of smoking | |
JP2001122795A (ja) | 感染性疾患予防・治療剤 | |
US6916845B2 (en) | Method for prevention and treatment of male and female sexual dysfunction | |
EP3868373B1 (en) | Use of a cannabinoid composition in the treatment of neurodermatitis | |
JP3615704B2 (ja) | 喫煙制御の改良組成物および方法 | |
KR101456953B1 (ko) | 이카리시드 ii의 남성 또는 여성 성기능장애의 예방 또는 치료제 제조에서의 용도 | |
KR100779419B1 (ko) | 중독성이 경감된 진통제 | |
RU2147242C1 (ru) | Средство для лечения табакокурения | |
AU748301B2 (en) | Improved compositions and methods for the control of smoking | |
Brinker | Yerba santa as a Respiratory and Flavor Aid. | |
CN114796318A (zh) | 桑叶总生物碱在制备防治脑缺血损伤作用药物中的应用 | |
Lukas | Human studies of kudzu as a treatment for alcohol abuse | |
Pace et al. | The Medical Use of Marihuana and THC in Perspective | |
JPH0543476A (ja) | 抗アレルギー剤および抗アレルギー剤を含有する飲食物 | |
JP2001039882A (ja) | 糖尿病の予防・治療製剤および該製剤を用いた糖尿病の予防・治療方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060530 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060821 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20061002 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061129 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070213 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070426 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070619 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070718 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100727 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110727 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120727 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120727 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130727 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |